PT  - JOURNAL ARTICLE
AU  - Mosley, Mary
ED  - Schmieder, Roland E.
TI  - Left Ventricular Remodeling Reduced with Olmesartan in ROADMAP
DP  - 2013 Dec 01
TA  - MD Conference Express
PG  - 13--14
VI  - 13
IP  - 17
4099  - http://mdc.sagepub.com/content/13/17/13.2.short
4100  - http://mdc.sagepub.com/content/13/17/13.2.full
AB  - A prespecified analysis of left ventricular hypertrophy (LVH) as evaluated by electrocardiography from the Olmesartan Medoxomil in Diabetes Mellitus study [ROADMAP] showed that olmesartan significantly reduced LV remodeling in patients with type 2 diabetes mellitus, independent of blood pressure, age, and sex.